In a promising development for type 1 diabetes treatment, researchers have developed a network of nanoscale particles that can be injected into the body and release insulin when blood-sugar levels rise, maintaining normal blood sugar levels for more than a week in animal-based laboratory tests.
The work was done by researchers at North Carolina State University, the University of North Carolina at Chapel Hill, the Massachusetts Institute… read more













